Report #2874155

Overview

Sex

Female

Age

Age unknown

State

AR

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

the administration of Havrix after only 2 months after the initial dose was given; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 78-year-old female patient who received HAV (Havrix) (batch number 4T93R, expiry date 07-NOV-2026) for prophylaxis. Concomitant products included HEPATITIS A VACCINE INACT (HAVRIX). On an unknown date, the patient received the 2nd dose of Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced drug dose administration interval too short (Verbatim: the administration of Havrix after only 2 months after the initial dose was given). The outcome of the drug dose administration interval too short was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 18-NOV-2025 The Vaccine Administration Facility was the same as Primary Reporter. The batch number was not provided upon follow- up with the reporter

Other medications

HAVRIX